-
The Current Status and Future Impact of Targeted Therapies in Non-Hodgkin Lymphoma
Compared with standard chemotherapy, targeted agents for non-Hodgkin lymphoma have greater tumor specificity, a better toxicity profile, and the potential for better long-term outcome.
April 02, 2013
-
Management of Unsuspected Pulmonary Embolism in Cancer Patients
This study focuses on the prevalence, clinical characteristics, treatment, management, and outcomes of unsuspected pulmonary embolism in patients with cancer.
February 01, 2013
-
Immunomodulator Drug-Based Therapy in Myeloma and the Occurrence of Thrombosis
Should patients receiving immunomodulator drugs for multiple myeloma receive concomitant thromboprophylaxis? The current review explains why and how.
December 07, 2012
-
Hypercoagulability in Beta-Thalassaemia: A Status Quo
To help prevent thrombotic events in thalassemia, use of splenectomy should be restricted, as no clinical trials have yet determined other optimal preventive strategies.
November 09, 2012
-
Management of Joint Bleeding in Hemophilia
The optimal dose and regimen to control acute hemarthrosis and to prevent arthropathy in patients with hemophilia is still unknown.
September 20, 2012
-
Clinical Management of the Hypereosinophilic Syndromes
What is the best treatment strategy for cases of hypereosinophilic syndromes? The current review evaluates the therapeutic options.
July 10, 2012
-
Risk Stratification in Waldenström Macroglobulinemia
What is the best practice for determining the prognosis of patients with Waldenström macroglobulinemia? The current review provides evidence-based answers.
April 04, 2012
-
Management of Myeloma-Associated Renal Dysfunction in the Era of Novel Therapies
How should multiple myeloma be treated in the setting of renal impairment? The current review explores this question.
January 23, 2012
-
Treatment of Warfarin-Associated Coagulopathy With Vitamin K
What is the best practice for the management of warfarin-associated coagulopathy? The current review provides answers.
November 11, 2011
-
Transfusion Medicine for Trauma Patients: An Update
What is the latest evidence regarding the use of blood products in cases of severe trauma? The current review addresses this question.
September 23, 2011
-
Long-term Health Impacts of Hematopoietic Stem Cell Transplantation Inform Recommendations for Follow-up
Successful hematopoietic cell transplantation is a great achievement, but survivors are at a higher risk of chronic illness. This review describes these risks, as well as screening guidelines.
August 01, 2011
-
Managing Multiple Myeloma in the Elderly: Are We Making Progress?
Best treatment options for older vs younger patients with MM differ because of toxicities and older individuals' lower tolerance of chemotherapy.
June 14, 2011